bg
N

Nuvalent (NUVL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Nuvalent (NUVL)

Nuvalent, Inc. is a preclinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. The Company is advancing a pipeline of product candidates with parallel programs in cancers driven by genomic a... Read more

  • USD71.52
  • USD73.29
  • USD70.96
  • USD89.39
  • -1.30%
  • --
  • 607.27k
  • 3.9B
  • 37.13
  • 101.10%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App